ORIC Pharmaceuticals to Attend Upcoming Investor Conferences

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company specializing in treatments that counteract therapeutic resistance in cancer, has announced its participation in several upcoming investor conferences in June. The company, which is listed on Nasdaq under the ticker symbol ORIC, will engage in two significant events next month.

The first of these events is the Jefferies Global Healthcare Conference, where ORIC’s management will participate in a fireside chat scheduled for 10:30 a.m. Eastern Time on Wednesday, June 5, 2024. The second event is the Goldman Sachs 45th Annual Global Healthcare Conference, where they will again participate in a similar format on Monday, June 10, 2024, at 10:40 a.m. Eastern Time. These discussions will be accessible via webcasts on the investor section of ORIC's official website, with replays available for 90 days post-event.

ORIC Pharmaceuticals is committed to enhancing the lives of cancer patients through innovative treatments. The company's promising clinical-stage product candidates include:

1. ORIC-114: This brain-penetrant inhibitor aims to selectively target EGFR and HER2, demonstrating high efficacy against exon 20 insertion mutations. It is intended for use across multiple genetically defined cancers.

2. ORIC-944: An allosteric inhibitor of the polycomb repressive complex 2 (PRC2), specifically targeting the EED subunit, is being developed primarily for the treatment of prostate cancer.

3. ORIC-533: This orally bioavailable small molecule inhibits CD73, a key player in the adenosine pathway, which is believed to play a crucial role in resistance to chemotherapy and immunotherapy treatments. It is currently being developed for multiple myeloma.

In addition to these candidates, ORIC is advancing a range of precision medicines aimed at other critical mechanisms of cancer resistance. The company operates from its offices located in South San Francisco and San Diego, California.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!